We are live on ! Find out more
MME

Meag Munich Ergo Portfolio holdings

AUM $3.54B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+20%
3 Year Est. Return
+82.79%
5 Year Est. Return
+144.54%
10 Year Est. Return
+335.02%
AUM
$1.41B
AUM Growth
+$833M
Cap. Flow
+$768M
Cap. Flow %
54.53%
Top 10 Hldgs %
29.38%
Holding
246
New
36
Increased
47
Reduced
42
Closed
48

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$42M
2
UNH icon
UnitedHealth
UNH
+$41.6M
3
CSCO icon
Cisco
CSCO
+$41.1M
4
GD icon
General Dynamics
GD
+$37.7M
5
MET icon
MetLife
MET
+$37.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$11.8M
2
DIS icon
Walt Disney
DIS
+$7.85M
3
CI icon
Cigna
CI
+$7.3M
4
INTC icon
Intel
INTC
+$6.94M
5
LW icon
Lamb Weston
LW
+$6.24M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 17.7%
3 Healthcare 16.44%
4 Industrials 10.23%
5 Consumer Discretionary 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
1
UnitedHealth
UNH
$383B
$46.5M 3.3%
+91,866
New +$41.6M
CSCO icon
2
Cisco
CSCO
$436B
$46.3M 3.29%
725,676
+718,793
+10,443% +$41.1M
LOW icon
3
Lowe's Companies
LOW
$115B
$45.9M 3.26%
178,323
+127,219
+249% +$30.2M
MSFT icon
4
Microsoft
MSFT
$2.99T
$44.3M 3.15%
130,167
+3,661
+3% +$1.19M
MS icon
5
Morgan Stanley
MS
$332B
$41.8M 2.97%
+421,792
New +$42M
GD icon
6
General Dynamics
GD
$100B
$38.9M 2.77%
+186,909
New +$37.7M
PXD
7
DELISTED
Pioneer Natural Resource Co.
PXD
$38.1M 2.71%
209,548
+200,238
+2,151% +$36.8M
PM icon
8
Philip Morris
PM
$300B
$37.5M 2.67%
+396,554
New +$37.1M
MET icon
9
MetLife
MET
$59.8B
$37.3M 2.65%
+594,570
New +$37.3M
BDX icon
10
Becton Dickinson
BDX
$42.6B
$36.8M 2.61%
148,392
+148,084
+48,079% +$35.5M
RTX icon
11
RTX Corp
RTX
$262B
$36.1M 2.56%
+419,186
New +$36.5M
JPM icon
12
JPMorgan Chase
JPM
$901B
$32.9M 2.34%
+206,802
New +$34M
EXC icon
13
Exelon
EXC
$47B
$32.6M 2.32%
+794,178
New +$29.9M
PFE icon
14
Pfizer
PFE
$141B
$31.9M 2.27%
+544,383
New +$27M
LOGI icon
15
Logitech
LOGI
$14.6B
$31.8M 2.26%
376,619
-18,191
-5% -$1.52M
LLY icon
16
Eli Lilly
LLY
$1.02T
$31.6M 2.24%
113,435
+79,618
+235% +$20.2M
CE icon
17
Celanese
CE
$4.89B
$30.2M 2.14%
+181,028
New +$29.5M
ADM icon
18
Archer Daniels Midland
ADM
$41.3B
$29.7M 2.11%
+442,621
New +$28.6M
CMCSA icon
19
Comcast
CMCSA
$84.9B
$29.6M 2.1%
+583,061
New +$30.4M
MRK icon
20
Merck
MRK
$307B
$27.4M 1.95%
354,058
+347,433
+5,244% +$27.7M
SRE icon
21
Sempra
SRE
$59.3B
$27.1M 1.92%
+409,632
New +$26M
ETN icon
22
Eaton
ETN
$156B
$26.8M 1.91%
+155,914
New +$25.8M
TEL icon
23
TE Connectivity
TEL
$59.3B
$26.2M 1.86%
+162,554
New +$25.1M
CCI icon
24
Crown Castle
CCI
$34.1B
$24M 1.7%
114,906
+102,998
+865% +$19M
TFC icon
25
Truist Financial
TFC
$62.3B
$22.7M 1.61%
+386,448
New +$23.6M

Similar funds

Meag Munich Ergo's Q4 2021 Portfolio in Review

As of Q4 2021, Meag Munich Ergo held 246 positions worth $1.41B, up 145% from $575M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Meag Munich Ergo deployed $768M of net new capital in Q4 2021, opening 36 new positions and adding to 47 existing holdings. Its largest new stake was Morgan Stanley: 421,792 shares worth $41.8M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $11.8M trimmed.

  • Meag Munich Ergo's largest Q4 2021 buy was Morgan Stanley: 421,792 shares worth $41.8M.
  • Meag Munich Ergo added most to Cisco in Q4 2021, an estimated $41.1M increase.
  • Meag Munich Ergo's biggest Q4 2021 reduction was Johnson & Johnson, cutting an estimated $11.8M.
  • Meag Munich Ergo fully exited Lamb Weston in Q4 2021, selling an estimated $6.24M.
  • Meag Munich Ergo's ten largest holdings make up 29% of its $1.41B portfolio in Q4 2021.
  • Meag Munich Ergo opened 36 new positions and closed 48 in Q4 2021.
  • Meag Munich Ergo's portfolio value rose 145% quarter-over-quarter to $1.41B.

Based on Meag Munich Ergo's 13F filing for Q4 2021, filed 25 Jan 2022.